About Miat
Miat is a company based in Milan (Italy). It operates as a Reseller / Distribution. Miat offers products and services including Active Pharmaceutical Ingredients (APIs), Medical Devices, Finished Pharmaceutical Products, and Nutraceuticals. Miat operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Aparna Pharmaceuticals and Ami organics, among others.
- Headquarter Milan, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website miat.it
- Legal Name Miat S.P.A.
Products & Services of Miat
Miat offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Medical Devices, Finished Pharmaceutical Products, and Nutraceuticals.
Active ingredients are traded for pharmaceutical product development.
Medical devices are distributed for healthcare industry needs.
Finished pharmaceutical products are supplied to various markets.
Nutraceutical products are offered for health and wellness.
Competitors of Miat
Miat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Aparna Pharmaceuticals and Ami organics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | – | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs | |
| aparnapharma.com | 2008 | Hyderabad, India | $674,328 | 328 | API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | |
| amiorganics.com | 2007 | Surat, India | – | 4 | Advanced API intermediates are manufactured for pharmaceutical use. | |
| dudechem.com | 2019 | Berlin, Germany | $6.98M | – | CDMO focused on manufacturing of APIs and intermediates | |
| leadsynbio.com | 2015 | Suzhou, China | – | – | CDMO focused on intermediates manufacturing services | |
| hsbiopharm.com | 2004 | Hangzhou, China | – | – | APIs, intermediates, and finished dosage forms are manufactured. | |
| veranova.com | 2022 | Wayne, United States | – | – | APIs and intermediates are manufactured by Veranova as a CDMO. |
Detailed competitors of Miat
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Miat
10 companies that operate in the same segment as Miat (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Miat
Miat is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Miat is involved in the trade of active pharmaceutical ingredients, intermediates, finished pharmaceutical products, medical devices, and nutraceuticals. The company operates in the pharmaceutical, cosmeceutical, and nutraceutical sectors, serving as a business bridge between East and West. With 50 years of experience, Miat is recognized for its expertise and reliability as a partner. Commercial relationships are maintained with 51 countries worldwide, and over 400 active ingredients are traded to support various industries.
Miat's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Miat offers Active Pharmaceutical Ingredients (APIs), Medical Devices, Finished Pharmaceutical Products, and Nutraceuticals.
Miat operates through Miat S.P.A..